Join
Live feed
·
NEWSReleasevia Quantisnow
SBC Medical Group Holdings Incorporated logo

Emerging Growth Research Maintains Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Strategic U.S. Market Entry

ByQuantisnow·Wall Street's wire, on your screen.
SBC· SBC Medical Group Holdings Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SBC (SBC Medical Group Holdings Incorporated) and more on Quantisnow.